Search research articles
Contact Us
Filters
Showing results (11-20 of 253) with videos related to
Page
of 26
Sort By:
The Lancet. Neurology
|
July 12, 2011
Combining statins with interferon β in multiple sclerosis: think twice, it might not be all right
Scott S Zamvil, Lawrence Steinman
Current Opinion in Neurology
|
March 31, 2016
Beginning of the end of two-stage theory purporting that inflammation then degeneration explains pathogenesis of progressive multiple sclerosis
Lawrence Steinman, Scott S Zamvil
Current Opinion in Neurology
|
November 11, 1999
Pathogenesis, diagnosis, and treatment of acute disseminated encephalomyelitis
O Stüve, S S Zamvil
Neurology
|
October 9, 2002
Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS
Scott S Zamvil, Lawrence Steinman
The Western Journal of Medicine
|
March 1, 1989
Autoimmune demyelinating disease
S S Zamvil, L Steinman
Annual Review of Immunology
|
January 1, 1990
The T lymphocyte in experimental allergic encephalomyelitis
S S Zamvil, L Steinman
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 2020
The immune signatures of multiple sclerosis: Lessons from twin studies
Pablo Villoslada, Scott S Zamvil
Expert Review of Clinical Pharmacology
|
June 16, 2012
Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis
Wolfgang Brück, Scott S Zamvil
The Journal of Clinical Investigation
|
June 23, 2020
Microglia complement astrocytes in neuromyelitis optica
Zahra Moinfar, Scott S Zamvil
Neurology
|
July 9, 2010
FTY720 and central memory: out of sight, out of mind
Anthony J Slavin, Scott S Zamvil
Page
of 26
Search research articles
Search
Showing results (11-20 of 253) with videos related to
Sort By:
Page
of 26
The Lancet. Neurology
|
July 12, 2011
Combining statins with interferon β in multiple sclerosis: think twice, it might not be all right
Scott S Zamvil, Lawrence Steinman
Current Opinion in Neurology
|
March 31, 2016
Beginning of the end of two-stage theory purporting that inflammation then degeneration explains pathogenesis of progressive multiple sclerosis
Lawrence Steinman, Scott S Zamvil
Current Opinion in Neurology
|
November 11, 1999
Pathogenesis, diagnosis, and treatment of acute disseminated encephalomyelitis
O Stüve, S S Zamvil
Neurology
|
October 9, 2002
Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS
Scott S Zamvil, Lawrence Steinman
The Western Journal of Medicine
|
March 1, 1989
Autoimmune demyelinating disease
S S Zamvil, L Steinman
Annual Review of Immunology
|
January 1, 1990
The T lymphocyte in experimental allergic encephalomyelitis
S S Zamvil, L Steinman
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 2020
The immune signatures of multiple sclerosis: Lessons from twin studies
Pablo Villoslada, Scott S Zamvil
Expert Review of Clinical Pharmacology
|
June 16, 2012
Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis
Wolfgang Brück, Scott S Zamvil
The Journal of Clinical Investigation
|
June 23, 2020
Microglia complement astrocytes in neuromyelitis optica
Zahra Moinfar, Scott S Zamvil
Neurology
|
July 9, 2010
FTY720 and central memory: out of sight, out of mind
Anthony J Slavin, Scott S Zamvil
Page
of 26